|
 Wanbury Limited has announced the appointment of Prakash Venkatraman as president of the API business. With a stellar career spanning over three decades, Venkatraman brings a wealth of experience in API operations, P&L management, and business strategy.
Venkatraman holds a Bachelor's degree in chemical engineering and a Master's degree in management studies from Mumbai University.
Venkatraman most recently served as senior vice president of the API business at Shilpa Pharma Lifesciences for over 3 years. In this role, he spearheaded the API division, driving growth and delivering on revenue and EBITDA targets.
Previously, Venkatraman led global sales and business development for Sun Pharma's API division as senior vice president. Venkatraman spent 8 years at Jubilant Life Sciences as senior vice president of the API business establishing Jubilant as a global leader in specific molecules and expanding capacity to meet surging demand.
Venkatraman's career also includes senior leadership roles at Wockhardt, Ranbaxy, and Kopran, where he consistently delivered on organizational objectives.
Wanbury is confident that Venkatraman's strong leadership, problem-solving skills, and strategic vision will elevate our success and significantly contribute to achieving our business goals and objectives.
Established in 1988, listed on the National Stock Exchange of India and BSE, Wanbury has a strong presence in API global market and domestic branded formulation with its API being exported to over 50 countries and has Pan-India formulation presence. The company has US FDA & EU GMP approved facilities at Tanuku (Andhra Pradesh) and Patalganga (Maharashtra).
|